Atlas Trials

A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia

Clinical trial NCT07573670 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07573670
Sponsor
The First Affiliated Hospital of Soochow University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Newly Diagnosed Mixed Phenotype Acute Leukemia
Start date
2026-05-01
Primary completion
2027-12-31
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.